Israeli Cancer Detection Check-Cap Looking to Raises $24 Million in Nasdaq IPO
Check-Cap Ltd., a clinical stage medical diagnostics company engaged in the development of a preparation-free ingestible imaging capsule that utilizes low-dose X-rays for the screening for colorectal cancer, More...
Israel’s Check-Cap Planning $15 Million NASDAQ IPO
Israel’s Check-Cap Ltd., a clinical stage medical diagnostics company engaged in the development of gastrointestinal imaging devices for the screening for colorectal cancer, announced that it has filed More...
Foamix Disappointing IPO Drops Share Price to $6
Israeli biomedical firm Foamix is moving ahead with its New York IPO, but has greatly reduced its expectations, dropping it’s per share asking price to only $6 from the previously expected $10 to $12 range. The More...
Liver Disease Biotech Galmed Files For A $35 Million IPO
– Galmed Pharmaceuticals Ltd., a clinical-stage biotech developing therapies for liver diseases and gallstones, filed on Thursday with the SEC to raise up to $35 million in an initial public offering, More...
Oramed Pharmaceuticals Files to Raise $100 Million
– Insulin tablet developer Oramed Pharmaceuticals has published a draft prospectus. – – Insulin tablet developer Oramed Pharmaceuticals Inc. (Nasdaq:ORMP) has published a draft prospectus More...